Benzoate Drugs for Traumatic Brain Injury
Journal of Clinical & Experimental Immunology · 14.03.2026 · 11 (01) · 01-10
DOI: 10.33140/jcei.11.01.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical & Experimental Immunology, online erschienen am 14.03.2026. Verfasst von Swarupa Pahan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research and Development, Jesse Brown Veterans Affairs Medical Center, Chicago, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NCCIH NIH HHS.
Abstract (Originalsprache)
Traumatic brain injury (TBI) is an acute disorder with prolonged complexities that affirm to be the leading cause of deaths and disabilities in US. The pathophysiology of TBI comprises of multiple complex processes. An impactful insult results in tissue damage, neuroinflammation, impaired cerebral blood flow, BBB disruption, and demyelination, leading to neurodegeneration and functional impairments. There are no specific treatments for TBI. Recent studies highlight the potential efficacy of the following benzoates for attenuating TBI pathologies in rodents: • Sodium benzoate, a metabolite of cinnamon, a widely used food additive and a Food and Drug Administration (FDA)-approved drug for glycine encephalopathy • Glyceryl tribenzoate, FDA-approved flavoring element being used in food and food packing productions In this review, we have made a genuine attempt to evaluate the significance of these two benzoates as prospective therapeutic options for TBI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Research and Development, Jesse Brown Veterans Affairs Medical Center, Chicago, USA.
- Department of Neurological Sciences, Rush University Medical Center, Chicago, USA.
Förderung
- BLRD VA
- NCCIH NIH HHS
Zitieren
APA
Pahan, S., & Pahan, K. (2026). Benzoate Drugs for Traumatic Brain Injury. Journal of Clinical & Experimental Immunology, 11(01), 01-10. https://doi.org/10.33140/jcei.11.01.02
Vancouver
Pahan S, Pahan K. Benzoate Drugs for Traumatic Brain Injury. Journal of Clinical & Experimental Immunology. 2026;11(01):01-10. doi:10.33140/jcei.11.01.02
BibTeX
@article{Pahan2026,
author = {Pahan, Swarupa and Pahan, Kalipada},
title = {Benzoate Drugs for Traumatic Brain Injury},
journal = {Journal of Clinical & Experimental Immunology},
year = {2026},
volume = {11},
number = {01},
pages = {01--10},
doi = {10.33140/jcei.11.01.02}
}
EUVIMED